Abstract

Background and ObjectivesABO discrepancies occur when the reactions in forward grouping are not corroborative to those in the reverse grouping due to weak subgroups of A and/or B, missing or weak ABO antibodies or unexpected alloantibodies. We aimed to determine the prevalence of ABO discrepancies in our donor population and to know the causes by using a standard classification.Materials and MethodsIt was a retrospective study on donor samples. For all the discrepant samples, the ABO and RhD grouping was repeated using tube technique. Adsorption–elution testing was done for detecting weak subgroups of A and B. Antibody screen (3‐cell) and identification (11‐cell) were done by gel technique (Bio‐Rad, Switzerland).ResultsWe detected 93 (0·064%) ABO discrepancies out of the total 144279 donor samples tested. The ABO discrepancies were due to weak anti‐B antibody (33/93; 35·5%), weak anti‐A antibody and weak subgroups of A (24 each; 25·8% each) and weak subgroups of B (5/93; 5·4%). Agglutination with O cells was observed in 7 (7·5%) samples at room temperature testing. The alloantibodies identified in these samples were anti‐M (5) and anti‐Lea in (1), while the remaining 1 sample was of ‘Bombay’ (Oh) phenotype. The autologous control was negative for all the samples.ConclusionThe prevalence of ABO discrepancies in our donor population is 0·064%.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call